STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options

Core Viewpoint - Kaskela Law LLC is investigating the fairness of the proposed buyout of STAAR Surgical Company by Alcon at a price of $28.00 per share, which is significantly lower than the company's recent trading prices and 52-week high [1][3]. Group 1: Buyout Details - On August 5, 2025, STAAR announced its agreement to be acquired by Alcon for $28.00 per share in cash [2]. - Many STAAR shareholders purchased their shares at prices above $30.00, indicating potential dissatisfaction with the buyout price [2]. Group 2: Investigation Focus - The investigation aims to determine if STAAR investors are receiving adequate monetary consideration for their shares [3]. - It will also assess whether the company's officers or directors breached their fiduciary duties or violated securities laws in agreeing to the buyout price [3]. Group 3: Shareholder Impact - The proposed buyout price of $28.00 per share is notably lower than STAAR's 52-week high of $38.60 per share, raising concerns among investors [3].